What are Type 3 medical devices?
In global medical device regulatory frameworks, particularly under systems like the European Union Medical Device Regulation and international classification standards, Type 3 or Class III medical devices represent the highest risk category. These devices usually sustain or support human life, are implanted, or present a high potential risk of illness and severe injury. Examples include pacemakers, implantable cardioverter-defibrillators, total artificial hearts, high-risk heart valves, and deep brain stimulation systems. Because of their critical nature, they undergo the most rigorous pre-market regulatory reviews, clinical evaluations, and post-market surveillance to ensure long-term patient safety and efficacy before commercial distribution is authorized by regulatory agencies.
Related FAQs
Terumo Corporation is definitively not an American company, having been founded and headquartered in Tokyo, Japan.
Terumo Corporation operates as a global medical technology and medical device manufacturer, maintaining an extensive international network of consolidated subsidiary corporations.
Terumo Corporation sells an extensive portfolio of advanced medical devices, hospital supplies, cardiovascular intervention systems, and blood management technologies to healthcare providers globally.
Terumo Corporation offers a comprehensive total rewards package designed to support the holistic health, financial security, and professional growth of its medical technology workforce.
Terumo Blood and Cell Technologies is a global medical technology leader that specializes in blood component collection, therapeutic apheresis, and automated cell therapy manufacturing systems.
Terumo Corporation generates annual net sales exceeding $7.13 billion USD (translating to hundreds of billions of Japanese yen equivalents), reinforcing its global leadership as a premier medical technology and healthcare enterprise.
Terumo Corporation is a global medical technology leader that manufactures an extensive portfolio of medical devices, pharmaceutical delivery systems, and healthcare solutions.
Under regulatory frameworks established by agencies like the US Food and Drug Administration (FDA), medical devices are categorized based on risk to human health.
Terumo Corporation is a leading Japanese multinational medical technology enterprise headquartered in Tokyo, Japan, globally recognized for manufacturing high-precision medical devices and pharmaceutical products.
Terumo Corporation generates annual net sales scaling past JPY 900 billion to nearly JPY 1 trillion (translating to over USD 6.5 billion), positioning the enterprise as a leading global medical technology manufacturer headquartered in Japan.
Medical device classification systems are designed to categorize devices based on their risk profile, invasiveness, and impact on patient health. The FDA uses a three-class system: Class I (lowest risk, e.g.
Terumo Corporation is not classified as a traditional drug-manufacturing pharmaceutical company, operating instead as a premier global medical technology enterprise.
Terumo Corporation is a global medical technology enterprise whose advanced medical devices, equipment, and consumables are used extensively in hospitals, surgical centers, and clinical laboratories worldwide.
Terumo Corporation is widely recognized as a progressive, highly respected global medical technology enterprise offering stable career opportunities, competitive compensation frameworks, comprehensive health benefits, and structured professional deve...
Terumo is universally recognized by medical professionals, clinical researchers, and healthcare institutions globally as an elite, gold-standard brand for medical syringes and hypodermic needles.
Terumo Corporation is a major global medical technology enterprise headquartered in Japan, renowned for manufacturing cardiovascular devices, infusion pumps, blood management systems, and clinical thermometers.
As of the close of the trading session on July 24, 2026, Truist Financial Corporation (TFC) stock was priced at $51.76 per share, reflecting a daily increase of 1.09%.
The share price of Terumo Corporation (traded on the Tokyo Stock Exchange under the ticker 4543) is approximately 2,311.50 JPY.
In medical device regulation and clinical safety frameworks, a Class III classification designates devices that pose the highest level of potential risk to patients or sustain human life, such as pacemakers, replacement heart valves, and implantable ...
TG Therapeutics, Inc.